Accelerate Diagnostics, Inc., a prominent in vitro diagnostics company, has been revolutionizing the diagnosis of serious infections across the United States, Europe, and the Middle East. Known for its cutting-edge Accelerate Pheno system, the company has been providing unparalleled solutions for identifying and testing pathogens linked to severe or health care-associated infections. The platform is designed to help with the gram-positive and gram-negative organisms that contribute to such infections. In addition to this, Accelerate Diagnostics, Inc. also offers the Accelerate PhenoTest, which is a test kit created for the Accelerate Pheno system. This test kit provides both identification and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia. These conditions are often life-threatening and present a high mortality risk, which further underlines the importance of Accelerate Diagnostics, Inc.'s work. Founded as Accelr8 Technology Corporation in 1982, the company underwent a name change to Accelerate Diagnostics, Inc. in December 2012. Today, its headquarters are located in Tucson, Arizona. The company's mission is to continue providing advanced diagnostic solutions, emphasizing the importance of early diagnosis, efficient treatments, and ultimately, saving lives.
Accelerate Diagnostics's ticker is AXDX
The company's shares trade on the NASDAQ stock exchange
They are based in Tucson, Arizona
There are 201-500 employees working at Accelerate Diagnostics
It is acceleratediagnostics.com
Accelerate Diagnostics is in the Healthcare sector
Accelerate Diagnostics is in the Medical Appliances & Equipment industry
The following five companies are Accelerate Diagnostics's industry peers: